Literature DB >> 16040335

Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.

Yoshiyuki Ban1, Teruaki Tozaki, Matsuo Taniyama, Motowo Tomita, Yoshio Ban.   

Abstract

The etiology of the autoimmune thyroid diseases (AITDs), Graves' disease (GD) and Hashimoto's thyroiditis is largely unknown. However, genetic susceptibility is believed to play a major role. The cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene, encoding a negative regulator of the T-lymphocyte immune response, had been reported to be associated and/or linked to AITD. Recently, AITD susceptibility in the Caucasians was mapped to the 6.1-kb 3'UTR of the CTLA-4 gene, in which the single-nucleotide polymorphism (SNP), CT60, was most strongly associated with AITD. In order to determine the association of the CTLA-4 gene with AITD in the Japanese, case-control association analysis for the CT60 of the CTLA-4 gene using 264 AITD patients and 179 healthy controls was done. The frequency of the disease-susceptible G allele of the CT60 of the Japanese control was higher than that of the Caucasians (72.6 vs. 52.3%). However, the G allele of the CT60 was associated with GD (84.0 vs. 72.6%, P=0.0008) and AITD (80.1 vs. 72.6%, P=0.009) in the Japanese. Furthermore, the G allele of the CT60 was associated with the increased risk for GD [P=0.004, odds ratio (OR)=2.0] and AITD (P=0.03,OR=1.6) in a recessive model. These results suggested that the CTLA-4 gene is involved in the susceptibility for GD and AITD in the Japanese.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040335     DOI: 10.1080/08916930500050319

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  19 in total

1.  Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis.

Authors:  K Zaletel; B Krhin; S Gaberscek; A Bicek; T Pajic; S Hojker
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

Review 2.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 3.  Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Terry J Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

4.  Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease.

Authors:  Weizhen Fang; Zhixian Zhang; Jin Zhang; Zhenhua Cai; Hua Zeng; Mei Chen; Junqi Huang
Journal:  Biomed Rep       Date:  2015-07-27

Review 5.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

6.  Hashimoto's Thyroiditis: From Genes to the Disease.

Authors:  Katja Zaletel; Simona Gaberšček
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

7.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

8.  Genetic factors of autoimmune thyroid diseases in Japanese.

Authors:  Yoshiyuki Ban
Journal:  Autoimmune Dis       Date:  2011-12-27

9.  CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis).

Authors:  Dorota Pastuszak-Lewandoska; Ewa Sewerynek; Daria Domańska; Aleksandra Gładyś; Renata Skrzypczak; Ewa Brzeziańska
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

10.  Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha.

Authors:  Janina Krupińska; Waldemar Urbanowicz; Mariusz Kaczmarczyk; Grzegorz Kulig; Elżbieta Sowińska-Przepiera; Elżbieta Andrysiak-Mamos; Anhelli Syrenicz
Journal:  Thyroid Res       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.